Recombinant Photorhabdus luminescens subsp. laumondii Ribonuclease T (rnt)

Shipped with Ice Packs
In Stock

Description

Overview

Recombinant Photorhabdus luminescens subsp. laumondii Ribonuclease T (rnt) is a genetically engineered form of Ribonuclease T (RNase T) derived from the bacterium Photorhabdus luminescens subsp. laumondii . P. laumondii is a Gram-negative, bioluminescent bacterium known for its symbiotic relationship with entomopathogenic nematodes, which together infect and kill insect larvae . This bacterium produces a variety of toxins and antimicrobial compounds, contributing to its role as a biological control agent in agriculture .

Ribonuclease T (RNase T)

RNase T is an enzyme involved in the maturation, turnover, and quality control of RNA . It functions as a 3' to 5' exoribonuclease, degrading RNA molecules from the 3' end . In various pathogens, RNase II activity, to which RNase T belongs, has been linked to the regulation of virulence and motility .

Recombinant Production

Recombinant RNase T is produced using genetic engineering techniques, where the gene encoding RNase T from P. luminescens subsp. laumondii is inserted into a host organism for expression . Common host organisms include yeast, E. coli, baculovirus, and mammalian cells . The recombinant protein can be produced in various forms, including with an Avi-tag for biotinylation .

Function and Significance

RNase T is part of an essential RNA-degrading multiprotein complex . Its activity is correlated with the regulation of virulence, motility, cell surface properties, production of antimicrobial agents, and hemolytic activity .

Availability

Recombinant Photorhabdus luminescens subsp. laumondii Ribonuclease T (rnt) is commercially available for purchase from CUSABIO . It is produced in different host systems, including yeast, E. coli, baculovirus, and mammalian cells . The protein is available in various forms, including Avi-tag biotinylated .

Genomic Context and Related Features

P. laumondii produces a vast array of putative toxins of unknown functions . One such toxin, encoded by locus tag, is a polymorphic antibacterial toxin that inhibits protein synthesis in a NAD+-dependent manner .

Table 1: Genomic Comparison Among Photorhabdus Genomes

CharacteristicP. temperata NC19P. luminescens TT01P. asymbiotica ATCC 43949
Genome size (bp)5,232,3435,688,9875,064,808
GC content (%)43.342.842.2
Total no. of protein-coding genes4,5554,8954,417
No. of genes for:
rRNA333
tRNA698585
CDS4,8084,9054,403
Transposases12911161

Table 2: Organization of the Photorhabdus Secondary Metabolome

Gene clusterApproximate locationTypeCluster presence in other Photorhabdus or Xenorhabdus genomesPredicted structure
PT01pte_ 00186-pte_ 00208NRPSplu3906-plu3935, pau_ 03747-pau_ 03784PT01
PT02pte_ 00292-pte_ 00298Butyrolactonepau_ 03747-pau_ 03784, pau_ 03338-pau_ 03397
PT03pte_ 00508-pte_ 00526Type I PKSpau_ 01186-pau_ 01226, plu3516–3550
PT04pte_ 00783-pte_ 00787NRPSplu3105-plu3144, pau_ 01452-pau_ 01511, XBJ1_ 1106-XBJ1_ 1149PT04
PT05pte_ 00840-pte_ 00877NRPSplu3105-plu3144, pau_ 01452-pau_ 01511PT05
PT06pte_ 01018-pte_ 01031NRPSUniquePT06
PT07pte_ 01583-pte_ 01602Type II PKSplu4179–4210
PT08pte_ 02299-pte_ 02346NRPSplu0164-plu0208PT08
PT09pte_ 02429-pte_ 02439BacteriocinUnique
PT10pte_ 02479-pte_ 02493Terpeneplu4322-plu4359
PT11pte_ 02783-pte_ 02807Type III PKSpau_ 02342-pau_ 02390, plu2164-plu2205, XNC1_ 2270-XNC1_ 2323
PT12pte_ 03084-pte_ 03100NRPS-type I PKSXBJ1_ 2661-XBJ1_ 2722PT12
PT13pte_ 03528-pte_ 03541NRPSXNC1_ 1677-XNC1_ 1733, XBJ1_ 2662-XBJ1_ 2722PT13
PT14pte_ 03726-pte_ 03757NRPSpau_ 01786-pau_ 01824, plu2716-plu2754
PT15pte_ 04021-pte_ 04055NRPSplu0874-plu0915PT15
PT16pte_ 04169-pte_ 04189Bacteriocin-NRPSPT16
PT17pte_ 04198-pte_ 04227HglDE-likepau_ 00901-pau_ 00936
PT18pte_ 04484-pte_ 04523NRPSplu2642-plu2670PT18

Product Specs

Form
Lyophilized powder
Note: While we will prioritize shipping the format currently in stock, please specify any format requirements in your order notes for customized preparation.
Lead Time
Delivery times vary depending on the purchasing method and location. Please contact your local distributor for precise delivery estimates.
Note: All proteins are shipped with standard blue ice packs. Dry ice shipping requires advance notification and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to consolidate the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our standard glycerol concentration is 50%, which can serve as a guideline.
Shelf Life
Shelf life depends on storage conditions, buffer composition, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized forms have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquot for multiple uses to prevent repeated freeze-thaw cycles.
Tag Info
The tag type is determined during manufacturing.
The tag type will be determined during production. If you require a specific tag, please inform us, and we will prioritize its development.
Synonyms
rnt; plu2603; Ribonuclease T; EC 3.1.13.-; Exoribonuclease T; RNase T
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-217
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Photorhabdus luminescens subsp. laumondii (strain DSM 15139 / CIP 105565 / TT01)
Target Names
rnt
Target Protein Sequence
MSDKKAPNVL SGRFRGYYPV VIDVETGGFN AKTDALLEIA AVTLEMDGEG WLTPGESLHF HIEPFEGANL EPAALEFTGI DPLNPLRGAV SEYEALHAIF KMVRKGIKNN HCNRAIIVAH NANFDHSFVM AATERTGLKR NPFHPFATFD TAALGGLVLG QTILAKACIT AGIPFDNNQA HSALYDTDRT AELFCEMVNR WKQLGGWPLT TTAEKTG
Uniprot No.

Target Background

Function
This ribonuclease trims short 3' overhangs from various RNA species, resulting in a one or two nucleotide 3' overhang. It plays a crucial role in tRNA end turnover, specifically removing the terminal AMP residue from uncharged tRNA (tRNA-C-C-A). It also appears to be involved in tRNA biosynthesis.
Database Links

KEGG: plu:plu2603

STRING: 243265.plu2603

Protein Families
RNase T family

Q&A

What is Photorhabdus luminescens subsp. laumondii and what is its genomic profile?

Photorhabdus luminescens subsp. laumondii is an entomopathogenic bacterium that forms a symbiotic association with Heterorhabditis nematodes. The bacterium is part of the Photorhabdus genus, which is divided into three species: P. luminescens, P. temperata, and P. asymbiotica. Specifically, P. luminescens subsp. laumondii HP88 has a 5.27-Mbp draft genome with a G+C content of 42.4% and contains 4,243 candidate protein-coding genes . This bacterium is notable for its bioluminescence production and its ability to produce multiple toxins and antimicrobial compounds. The genome sequence has been deposited in GenBank under the accession number LJPB00000000, making it accessible for researchers interested in studying various aspects of this organism including ribonucleases .

How do you design primers for cloning Ribonuclease T from P. luminescens subsp. laumondii?

When designing primers for cloning Ribonuclease T from P. luminescens subsp. laumondii, researchers should follow these methodological steps:

  • Obtain the complete gene sequence from genomic databases using the draft genome sequence information (accession number LJPB00000000) .

  • Design primers with the following considerations:

    • Include appropriate restriction sites that are absent in the target gene

    • Add 3-6 base pairs flanking the restriction sites to ensure efficient enzyme digestion

    • Maintain a GC content of 40-60% to match the organism's genomic G+C content of 42.4%

    • Ensure primer melting temperatures are within 5°C of each other

  • Validate primer specificity using in silico PCR against the P. luminescens genome to avoid non-specific amplification.

  • Consider codon optimization if the recombinant protein will be expressed in a heterologous system like E. coli, as P. luminescens has a distinct codon usage pattern reflecting its 42.4% G+C content .

Example primer design for P. luminescens rnt gene (conceptual):
Forward: 5'-GAATTCATGXXXXXXXXXXXXXXX-3' (EcoRI site underlined)
Reverse: 5'-CTCGAGTTAXXXXXXXXXXXXXXX-3' (XhoI site underlined)

What expression systems are optimal for producing recombinant P. luminescens Ribonuclease T?

The optimal expression systems for producing recombinant P. luminescens Ribonuclease T depend on research objectives and intended applications. Below is a methodological comparison of common expression systems:

Expression SystemAdvantagesLimitationsRecommended Conditions for rnt
E. coli pET systemHigh yield, rapid growth, well-established protocolsPotential inclusion body formation, lack of post-translational modificationsInduction: 0.1-0.5 mM IPTG, 16-18°C overnight to reduce inclusion bodies
E. coli pBAD systemTitratable expression, reduced leaky expressionLower yields than pET system0.002-0.2% L-arabinose, 30°C for 4-6 hours
Cold-adapted expression systemsBetter folding of temperature-sensitive proteinsMore complex handlingRelevant for P. luminescens proteins due to temperature restriction properties
Cell-free systemsAvoids toxicity issues, rapid productionHigher cost, lower yieldUseful for initial characterization studies

For P. luminescens proteins, temperature considerations are particularly important given the bacterium's known temperature restrictions . Research shows that P. luminescens has temperature-restricted growth, partly regulated by the TRL operon, which might influence protein folding and activity . Therefore, expression at lower temperatures (16-25°C) may improve the functional yield of recombinant Ribonuclease T. Additionally, considering that P. luminescens produces multiple toxins that might co-purify with the target protein, incorporation of affinity tags (His6, GST, or MBP) is recommended for efficient purification.

What purification challenges are specific to recombinant P. luminescens Ribonuclease T?

Purifying recombinant Ribonuclease T from P. luminescens presents several specific challenges that researchers should address methodologically:

  • RNase contamination control: As Ribonuclease T is an RNA-degrading enzyme, maintaining RNA integrity during experimental procedures requires stringent RNase-free conditions. Researchers should:

    • Use DEPC-treated water and buffers

    • Implement dedicated equipment and work areas

    • Consider temporary inhibition of RNase activity during certain purification steps

  • Potential co-purification with host RNases: When expressed in E. coli or other hosts, distinguishing the recombinant P. luminescens Ribonuclease T from host RNases requires:

    • Designing constructs with differentiating tags or domains

    • Employing substrate specificity assays to confirm identity

    • Using immunological detection with antibodies specific to tagged recombinant protein

  • Maintenance of enzymatic activity: P. luminescens proteins may have evolved unique structural features related to their entomopathogenic lifestyle and temperature sensitivity , requiring:

    • Optimization of buffer conditions (pH, salt concentration, stabilizing agents)

    • Temperature control during purification steps

    • Activity testing at multiple stages of purification

  • Potential toxin contamination: P. luminescens produces numerous toxins and antimicrobial compounds that might co-purify with the target protein, necessitating:

    • Multiple chromatography steps with different separation principles

    • Validation of final product purity using proteomic approaches

    • Testing for cytotoxic effects in biological assays

A typical purification protocol would involve affinity chromatography (if the construct contains an affinity tag), followed by ion-exchange chromatography and size-exclusion chromatography, with RNase activity assays performed at each step to track the target protein.

How do you assess the enzymatic activity of purified recombinant P. luminescens Ribonuclease T?

Assessment of enzymatic activity for purified recombinant P. luminescens Ribonuclease T should employ multiple complementary methodologies:

  • Substrate degradation assays:

    • Use synthetic RNA oligonucleotides with 3' fluorescent labels

    • Monitor the release of fluorescent nucleotides over time

    • Calculate initial velocity from linear portions of progress curves

    • Determine kinetic parameters (Km, kcat, kcat/Km) under various conditions

  • Gel-based activity assays:

    • Incubate the enzyme with radiolabeled or fluorescently labeled RNA substrates

    • Analyze reaction products using polyacrylamide gel electrophoresis

    • Quantify substrate degradation patterns to characterize 3'→5' exonuclease activity

  • Temperature-dependent activity profiling:

    • Given P. luminescens' temperature-restricted growth , perform activity assays at temperatures ranging from 15°C to 42°C

    • Generate temperature-activity profiles to identify optimal conditions and thermal stability

  • Inhibition studies:

    • Test sensitivity to known RNase inhibitors

    • Evaluate the effects of divalent metal ions (Mg2+, Mn2+) on activity

    • Assess the impact of varying pH and ionic strength

  • Comparative analysis with E. coli Ribonuclease T:

    • Perform side-by-side activity comparisons with the well-characterized E. coli homolog

    • Identify substrate preferences and catalytic efficiencies that might reflect adaptation to the insect host environment

Activity data should be presented with appropriate statistical analyses and controls to ensure reproducibility, especially considering that P. luminescens proteins may exhibit unique properties related to their entomopathogenic lifestyle and symbiotic relationship with nematodes .

How does temperature affect the expression and activity of recombinant P. luminescens Ribonuclease T?

Temperature plays a critical role in both the expression and activity of recombinant P. luminescens Ribonuclease T, particularly given the known temperature restriction in Photorhabdus. Research methodologies to investigate this relationship should include:

  • Temperature-dependent expression analysis:
    Studies have shown that P. luminescens has a temperature-restricted phenotype, with specific genetic elements like the TRL operon regulating growth at different temperatures . When expressing recombinant Ribonuclease T, researchers should monitor:

    • Expression levels at temperatures ranging from 15°C to 37°C

    • Protein folding efficiency and solubility at different temperatures

    • Impact of temperature shifts during induction and expression phases

  • Structural stability assessment:

    • Circular dichroism (CD) spectroscopy at varying temperatures to track secondary structure changes

    • Differential scanning calorimetry (DSC) to determine thermal transition points

    • Thermal shift assays using fluorescent dyes to monitor unfolding

  • Activity correlation with temperature:
    The TRL operon in P. luminescens appears to be involved in temperature-dependent regulation , suggesting that enzymes like Ribonuclease T may exhibit temperature-dependent activity profiles that reflect adaptation to their ecological niche. Researchers should:

    • Document enzymatic activity at 5°C increments between 15-42°C

    • Calculate activation energy (Ea) using Arrhenius plots

    • Compare temperature optima with the growth temperature range of the source organism

  • Genetic analysis of temperature adaptation:

    • Examine the genomic context of the rnt gene in P. luminescens

    • Investigate potential regulatory elements that might control expression in response to temperature

    • Consider the relationship between temperature adaptation and the bacterium's lifestyle as both a symbiont of nematodes and a pathogen of insects

This multi-faceted approach would yield valuable insights into how temperature influences both the production and function of recombinant P. luminescens Ribonuclease T, with implications for optimizing expression systems and understanding the enzyme's role in the bacterium's ecology.

What are the structural differences between P. luminescens Ribonuclease T and homologs from other bacteria?

Structural analysis of P. luminescens Ribonuclease T compared to homologs from other bacteria reveals adaptations potentially related to the organism's unique ecological niche. Although specific structural data for P. luminescens Ribonuclease T is not directly available in the search results, comparative genomics and structural prediction methodologies can provide significant insights:

  • Homology modeling approach:

    • Generate structural models using E. coli Ribonuclease T crystal structure as a template

    • Validate models using Ramachandran plots and QMEAN scores

    • Focus analysis on the catalytic domain and substrate binding regions

  • Key structural features comparison:

    FeatureP. luminescens RNase T (predicted)E. coli RNase TFunctional Implication
    Active site architecturePotentially adapted for broader substrate rangeWell-characterized Mg2+-dependent active siteMay reflect adaptation to processing RNA from insect hosts
    Temperature-sensitive regionsLikely contains flexible loops sensitive to temperatureStable at standard mesophilic temperaturesConnected to temperature-restricted growth
    Surface charge distributionPrediction suggests unique distributionKnown distribution optimized for tRNA processingMay indicate specialized RNA targets in P. luminescens
    Oligomeric statePotentially differs from E. coli homologPredominantly dimericCould affect substrate accessibility and processivity
  • Phylogenetic context analysis:

    • Construct phylogenetic trees including Ribonuclease T sequences from diverse bacteria

    • Identify sequence signatures specific to entomopathogenic bacteria

    • Correlate sequence divergence with ecological niches

  • Functional domain organization:

    • Analyze the conservation of DEDDh motif characteristic of the RNase T family

    • Examine potential insertions/deletions in loop regions that might affect substrate specificity

    • Investigate the presence of unique domains or motifs not found in other bacterial homologs

This structural comparison would provide valuable insights into how P. luminescens Ribonuclease T may have evolved specific adaptations related to the bacterium's lifecycle, including its temperature sensitivity and entomopathogenic properties .

How can recombinant P. luminescens Ribonuclease T be used in RNA processing studies?

Recombinant P. luminescens Ribonuclease T offers several methodological applications in RNA processing studies, particularly for researchers investigating specialized RNA metabolism:

  • tRNA 3' end processing systems:

    • Use purified recombinant Ribonuclease T to process precursor tRNAs in vitro

    • Compare processing efficiency with other bacterial RNases

    • Investigate temperature-dependent processing, reflecting the temperature sensitivity of P. luminescens

    • Analyze the precision of CCA terminus generation for aminoacylation

  • Structured RNA degradation studies:

    • Apply the enzyme to study degradation of structured RNAs with stable 3' ends

    • Examine substrate specificity differences compared to other exoribonucleases

    • Develop RNA structure probing applications based on the enzyme's processing patterns

  • Symbiosis-related RNA processing investigation:

    • Given P. luminescens' symbiotic relationship with nematodes , explore potential specialized RNA processing roles

    • Investigate processing of specific mRNAs involved in symbiosis or virulence

    • Study potential interactions with regulatory ncRNAs, particularly considering that Hfq-mediated regulation is important in P. luminescens and often involves temperature-sensitive ncRNAs

  • Methodology for investigating temperature-dependent RNA metabolism:

    • Use the recombinant enzyme to study RNA processing at different temperatures

    • Correlate processing efficiency with the temperature restriction phenotype of P. luminescens

    • Develop experimental systems to investigate how RNA metabolism adapts to temperature fluctuations during host invasion

  • Biotechnological applications:

    • Develop RNA 3' end trimming tools for preparing RNA samples for next-generation sequencing

    • Create specialized RNA processing reagents that function under unique conditions

    • Engineer RNase T variants with enhanced specificity for particular structured RNAs

Implementation of these methodologies would benefit from combining biochemical approaches with transcriptomic analyses of P. luminescens under various conditions to understand the biological context of Ribonuclease T function in this entomopathogenic bacterium.

What are common challenges in interpreting recombinant P. luminescens Ribonuclease T activity data?

Interpreting activity data for recombinant P. luminescens Ribonuclease T presents several methodological challenges that researchers should address systematically:

  • Temperature-dependent variability:
    P. luminescens exhibits temperature-restricted growth , suggesting that its proteins, including Ribonuclease T, may show unusual temperature-activity relationships. Researchers should:

    • Perform activity assays across a wider temperature range than standard (10-42°C)

    • Account for potential hysteresis effects when changing temperatures

    • Consider that activity peaks may not align with optimal growth temperatures

    • Control for temperature effects on substrate structure independent of enzyme activity

  • Substrate specificity interpretation:

    • Distinguish between general RNA degradation and specific processing activity

    • Control for co-purified contaminating RNases that may contribute to observed activity

    • Consider that P. luminescens may have evolved unique substrate preferences related to its lifestyle as both a symbiont and pathogen

  • Comparison with reference standards:

    • When comparing with E. coli Ribonuclease T, account for differences in optimal reaction conditions

    • Normalize activities appropriately when making cross-species comparisons

    • Consider evolutionary divergence when interpreting kinetic differences

  • Buffer composition effects:

    • Test multiple buffer systems as Photorhabdus produces various antimicrobial compounds that might influence enzyme stability

    • Evaluate the impact of divalent metal ion concentrations, particularly Mg2+ which is essential for RNase T activity

    • Consider that the intracellular environment of P. luminescens may differ from standard bacterial models

  • Data analysis and representation:

    • Employ statistical methods appropriate for non-linear enzyme kinetics

    • Use multiple technical and biological replicates to account for preparation variability

    • Present activity data in the context of the enzyme's physiological role in P. luminescens

By addressing these interpretation challenges methodically, researchers can more accurately characterize the unique properties of P. luminescens Ribonuclease T and its potential adaptations to the bacterium's ecological niche.

How do you troubleshoot loss of activity during purification of recombinant P. luminescens Ribonuclease T?

When encountering activity loss during purification of recombinant P. luminescens Ribonuclease T, researchers should implement a systematic troubleshooting approach:

  • Temperature-related activity loss:
    Given P. luminescens' temperature-restricted phenotype , temperature control during purification is critical:

    • Maintain all purification steps at consistent, moderate temperatures (15-25°C)

    • Avoid freeze-thaw cycles which may disproportionately affect P. luminescens proteins

    • Test activity recovery by incubating inactive preparations at various temperatures

    • Implement temperature gradient activity assays to identify potential temperature-dependent refolding

  • Buffer optimization strategy:

    • Systematically vary buffer components (pH, salt concentration, reducing agents)

    • Test addition of stabilizing agents (glycerol, betaine, sucrose)

    • Evaluate metal ion requirements, particularly Mg2+ which is essential for RNase activity

    • Consider adding trace amounts of RNA as a stabilizing factor

  • Protease contamination assessment:
    P. luminescens produces various proteases that might co-purify with the target protein:

    • Add protease inhibitor cocktails throughout purification

    • Monitor protein integrity by SDS-PAGE at each purification step

    • Perform Western blot analysis to detect degradation products

    • Consider purification under mild denaturing conditions followed by refolding

  • Methodical activity tracking:

    Purification StageActivity Testing MethodPotential IssuesIntervention Strategies
    Crude lysateQualitative RNA degradation assayInhibitors presentDilution series to identify inhibition
    After affinity chromatographyQuantitative kinetic assayTag interferenceOn-column tag cleavage
    Ion exchange fractionsSubstrate specificity assaySalt effectsDialysis before activity testing
    Final preparationComprehensive activity profileAggregationSize exclusion chromatography
  • Storage condition optimization:

    • Test stability in different storage buffers (varying glycerol %, salt concentration)

    • Compare activity retention at different storage temperatures (4°C, -20°C, -80°C)

    • Evaluate the effect of flash-freezing in liquid nitrogen versus slow freezing

    • Consider lyophilization with appropriate excipients for long-term storage

This systematic approach addresses both general protein purification challenges and specific considerations for P. luminescens proteins, which may have unique stability requirements related to the bacterium's lifecycle and environmental adaptations .

How do you design experiments to investigate potential regulatory interactions affecting P. luminescens Ribonuclease T activity?

Designing experiments to investigate regulatory interactions affecting P. luminescens Ribonuclease T activity requires a multifaceted approach that considers the unique biological context of this entomopathogenic bacterium:

  • Transcriptional regulation analysis:

    • Construct reporter fusions (GFP, luciferase) to the rnt promoter region

    • Monitor expression under various conditions relevant to the P. luminescens lifecycle:

      • Temperature shifts (15-37°C) to reflect the temperature restriction phenotype

      • Growth phase transitions (exponential vs. stationary)

      • Insect hemolymph-mimicking media to simulate host conditions

    • Perform chromatin immunoprecipitation (ChIP) to identify transcription factors binding to the rnt promoter

    • Analyze the impact of known P. luminescens regulators, including Rap/Hor homologs

  • Post-translational modification investigation:

    • Employ mass spectrometry to identify potential modifications

    • Create site-directed mutants at predicted modification sites

    • Compare activity profiles of wild-type and mutant proteins

    • Investigate temperature-dependent modifications that might connect to growth restriction

  • Protein-protein interaction studies:

    • Perform bacterial two-hybrid or pull-down assays to identify interaction partners

    • Use FRET-based approaches to confirm interactions in vivo

    • Investigate potential interactions with RNA metabolism proteins

    • Examine possible associations with quorum sensing components, as P. luminescens uses LuxS-dependent signaling

  • RNA-based regulation exploration:

    • Screen for small RNAs that might affect rnt expression

    • Investigate the role of Hfq, which mediates regulatory RNA interactions and is important in secondary metabolite production in P. luminescens

    • Analyze RNA structure changes at different temperatures that might affect translation efficiency

  • Environmental response correlation:

    • Monitor Ribonuclease T activity during:

      • Symbiotic phase (nematode association)

      • Pathogenic phase (insect infection)

      • Stationary phase (antibiotic production)

    • Correlate activity with production of bioluminescence and secondary metabolites

    • Develop in vivo activity assays using RNA substrates with sequence-specific fluorescent reporters

This comprehensive experimental design would help elucidate the regulatory network controlling P. luminescens Ribonuclease T, potentially revealing connections to the bacterium's unique lifecycle as both a symbiont of nematodes and a pathogen of insects, as well as its temperature-dependent growth characteristics .

What are promising applications of engineered P. luminescens Ribonuclease T variants in RNA research?

Engineered variants of P. luminescens Ribonuclease T present several promising applications in RNA research, leveraging the unique properties of this enzyme:

  • Temperature-responsive RNA processing tools:
    Given P. luminescens' temperature restriction phenotype , engineered temperature-sensitive variants could enable:

    • Temperature-controlled RNA processing in experimental systems

    • Selective degradation of target RNAs triggered by temperature shifts

    • Development of RNA thermosensors for synthetic biology applications

    • Investigation of temperature-dependent RNA structure-function relationships

  • Substrate specificity engineering:

    • Create variants with enhanced specificity for particular RNA structural motifs

    • Develop tools for selective processing of specific tRNA isoacceptors

    • Engineer variants that discriminate between host and pathogen RNAs

    • Design RNases with modified 3' end preferences for specialized RNA sequencing applications

  • Fusion proteins for targeted RNA modulation:

    • Create fusions with RNA-binding domains for sequence-specific targeting

    • Develop inducible systems for controlled RNA degradation in research applications

    • Engineer biosensors that couple RNA detection to nuclease activity

    • Design synthetic regulatory circuits utilizing controllable RNA processing

  • Structural biology platforms:

    • Use engineered catalytically inactive variants as RNA structure probes

    • Develop crystallization chaperones for structural studies of RNA-protein complexes

    • Create variants optimized for cryo-EM studies of RNA processing mechanisms

    • Engineer stable complexes for investigating transient RNA processing intermediates

  • Biotechnological applications:

    • Develop variants with enhanced stability for commercial RNA processing applications

    • Create enzymes optimized for specific RNA preparation workflows

    • Engineer variants with resistance to common inhibitors for robust performance in complex samples

    • Develop immobilized enzyme systems for continuous RNA processing applications

These engineering approaches would build upon the natural properties of P. luminescens Ribonuclease T, potentially incorporating adaptations related to the bacterium's lifecycle as both a symbiont and pathogen , while addressing specific needs in RNA research and biotechnology.

How might studying P. luminescens Ribonuclease T contribute to understanding bacterial adaptation to different hosts?

Studying P. luminescens Ribonuclease T offers unique insights into bacterial adaptation to different hosts through multiple research avenues:

  • Comparative genomics and evolution:

    • Analyze Ribonuclease T sequence conservation across Photorhabdus species with different host ranges

    • Compare enzyme properties between P. luminescens (insect pathogen) and P. asymbiotica (human pathogen)

    • Investigate whether rnt gene location is conserved in the genome, similar to how the TRL operon appears to be ancestral to specific Photorhabdus lineages

    • Examine selection pressures on the rnt gene across bacterial species with different lifestyles

  • Host-interaction RNA processing:

    • Investigate whether P. luminescens Ribonuclease T processes specific RNAs during insect infection

    • Study potential roles in modifying host RNAs as part of the pathogenic process

    • Examine activity against insect-specific RNA structures or modifications

    • Research potential connections to the bacterium's ability to overcome insect immune defenses

  • Temperature adaptation mechanisms:

    • Explore how Ribonuclease T function relates to the temperature restriction phenotype of P. luminescens

    • Compare activity profiles across temperatures relevant to different host environments

    • Investigate whether temperature-dependent activity contributes to host specificity

    • Study potential coordinated regulation with other temperature-responsive systems

  • Symbiosis-pathogenesis transition:

    • Analyze Ribonuclease T expression and activity during the transition from nematode symbiont to insect pathogen

    • Investigate connections to bioluminescence and antimicrobial compound production, which are characteristic of P. luminescens

    • Study potential roles in RNA turnover during metabolic transitions between host environments

    • Examine possible involvement in processing regulatory RNAs that control virulence factors

  • Host immune evasion strategies:

    • Research potential roles in degrading host immune signaling RNAs

    • Investigate whether Ribonuclease T contributes to survival in insect hemocoel

    • Study possible connections to the bacterium's ability to grow unrestricted in the insect host

    • Examine interactions with other virulence factors like Mcf toxin that affects insect hemocytes

This research would contribute valuable insights into how specialized RNA processing enzymes may facilitate bacterial adaptation to specific ecological niches, particularly in complex lifecycle patterns involving both symbiotic and pathogenic relationships.

What genomic and transcriptomic approaches could reveal the role of Ribonuclease T in P. luminescens lifecycle?

Comprehensive genomic and transcriptomic approaches can effectively elucidate the role of Ribonuclease T in the P. luminescens lifecycle through the following methodological strategies:

  • Comparative genomics analysis:

    • Perform detailed sequence comparisons of rnt genes across all sequenced Photorhabdus strains

    • Analyze genomic context of rnt to identify potential co-regulated genes

    • Examine conservation patterns among strains with different host preferences

    • Investigate potential horizontal gene transfer signatures, similar to analyses done for other P. luminescens genes

    • Map regulatory elements in the promoter region through phylogenetic footprinting

  • Transcriptome profiling during lifecycle transitions:

    • Implement RNA-seq analysis across key lifecycle stages:

      • Free-living phase

      • Nematode colonization

      • Initial insect infection

      • Late-stage insect infection

    • Quantify rnt expression patterns in relation to virulence genes

    • Correlate expression with temperature shifts (15-37°C) relevant to host transitions

    • Analyze co-expression networks to identify functional associations

  • RNA degradome sequencing:

    • Apply PARE (Parallel Analysis of RNA Ends) or similar techniques to map RNA cleavage sites genome-wide

    • Compare wild-type and rnt knockout strains to identify specific substrates

    • Analyze temperature-dependent changes in RNA degradation patterns

    • Identify potential regulatory RNA targets during host infection

  • Gene knockout and complementation studies:

    • Generate markerless deletion mutants of rnt using techniques similar to those used for TRL operon studies

    • Assess phenotypic consequences on:

      • Growth at different temperatures

      • Bioluminescence production

      • Antibiotic synthesis

      • Nematode colonization efficiency

      • Insect virulence

    • Perform complementation with both native and variant rnt genes

  • RNA structurome analysis:

    • Implement SHAPE-seq or similar approaches to map RNA structural changes in response to temperature

    • Compare RNA structural landscapes between wild-type and rnt mutants

    • Identify structured RNAs that may be preferential substrates

    • Analyze temperature-dependent structural changes in potential regulatory RNAs

  • Integration with multi-omics data:

    Data TypeExperimental ApproachExpected InsightsIntegration Strategy
    GenomicsWhole genome sequencing of multiple isolatesEvolutionary conservation patternsIdentify selection signatures in rnt
    TranscriptomicsRNA-seq under various conditionsExpression patterns and co-regulated genesNetwork analysis with virulence factors
    ProteomicsMass spectrometry of RNA-binding proteinsProtein-protein interactionsIdentify RNase T complexes
    MetabolomicsSecondary metabolite profilingCorrelation with antibiotic productionLink RNA processing to metabolic shifts

This multi-faceted approach would provide a comprehensive understanding of how Ribonuclease T functions within the complex lifecycle of P. luminescens, potentially revealing novel connections to the bacterium's temperature restriction phenotype , antimicrobial production , and host-adaptation mechanisms .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.